US Stock MarketDetailed Quotes

MDWD MediWound

Watchlist
  • 17.830
  • -0.060-0.34%
Close Dec 26 16:00 ET
192.39MMarket Cap-6.13P/E (TTM)

MediWound Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-15.53%-3.76M
31.00%-3.62M
-806.75%-4.61M
11.95%-10.47M
-230.75%-2.62M
28.80%-3.25M
0.06%-5.25M
116.04%652K
-33.30%-11.89M
189.49%2M
Net income from continuing operations
-368.21%-10.28M
-788.32%-6.31M
-163.44%-9.73M
65.73%-6.72M
76.63%-1.74M
47.70%-2.2M
121.04%916K
-2.90%-3.69M
-44.63%-19.6M
-79.25%-7.46M
Operating gains losses
750.93%4.56M
139.98%1.95M
1,312.16%6.18M
-169.76%-8.04M
-117.71%-1.95M
-1,198.15%-701K
-1,634.59%-4.88M
-292.45%-510K
9,391.94%11.52M
9,803.60%10.99M
Depreciation and amortization
6.49%361K
13.33%357K
21.45%368K
2.44%1.3M
21.83%346K
0.30%339K
-4.26%315K
-5.61%303K
2.75%1.27M
2.90%284K
Other non cash items
198.49%458K
80.77%-80K
-218.85%-145K
-691.74%-1.29M
55.23%-531K
-157.20%-465K
-277.78%-416K
-65.83%122K
-87.07%218K
-430.36%-1.19M
Change In working capital
118.18%98K
83.98%-304K
-147.13%-1.8M
132.25%2.34M
175.39%962K
75.17%-539K
6.64%-1.9M
316.04%3.81M
-4,571.60%-7.24M
-261.72%-1.28M
-Change in receivables
28.92%-177K
253.31%417K
-103.66%-238K
166.00%4.76M
75.10%-1.22M
59.05%-249K
78.06%-272K
1,533.70%6.51M
-4,448.19%-7.22M
-998.72%-4.92M
-Change in inventory
134.98%184K
117.79%103K
23.16%-448K
-25.66%-906K
792.04%782K
-478.42%-526K
-1,464.86%-579K
17.89%-583K
-380.54%-721K
-263.77%-113K
-Change in payables and accrued expense
-61.44%91K
21.30%-824K
47.52%-1.11M
-318.99%-1.52M
-62.59%1.4M
113.87%236K
-38.49%-1.05M
-252.50%-2.12M
366.28%695K
2,069.36%3.75M
Cash from discontinued investing activities
Operating cash flow
-15.53%-3.76M
31.00%-3.62M
-806.75%-4.61M
11.95%-10.47M
-230.75%-2.62M
28.80%-3.25M
0.06%-5.25M
116.04%652K
-33.30%-11.89M
189.49%2M
Investing cash flow
Cash flow from continuing investing activities
-145.13%-14.29M
110.91%2.85M
76.03%-1.78M
-7,035.34%-34.32M
109.85%5.03M
-7,185.00%-5.83M
-888.93%-26.08M
-4,551.88%-7.44M
-113.56%-481K
2,165.52%2.4M
Net PPE purchase and sale
29.26%-1.19M
-183.19%-3.02M
16.35%-1.26M
-1,064.68%-6.46M
-1,169.54%-2.21M
-1,930.12%-1.69M
-671.74%-1.07M
-840.63%-1.51M
-13.50%-555K
-50.00%-174K
Net investment purchase and sale
-201.96%-13.56M
120.86%5.34M
81.89%-1.13M
---29.8M
160.70%6.52M
---4.49M
-924.01%-25.59M
---6.24M
--0
--2.5M
Cash from discontinued investing activities
Investing cash flow
-145.13%-14.29M
110.91%2.85M
76.03%-1.78M
-7,035.34%-34.32M
109.85%5.03M
-7,185.00%-5.83M
-888.93%-26.08M
-4,551.88%-7.44M
-113.56%-481K
2,165.52%2.4M
Financing cash flow
Cash flow from continuing financing activities
2,948.56%20.71M
74.57%-103K
-102.88%-699K
-35.92%22.92M
-101.39%-204K
-106.17%-727K
44.37%-405K
140.68%24.25M
3,506.10%35.76M
8,370.06%14.64M
Net issuance payments of debt
5.00%-228K
-36.31%-214K
-37.85%-244K
----
----
-32.60%-240K
---157K
0.56%-177K
----
----
Net common stock issuance
--22.44M
--0
-98.02%499K
-35.10%24.91M
--0
--0
55.40%-248K
141.50%25.16M
--38.38M
--16.47M
Proceeds from stock option exercised by employees
--600K
--111K
----
--0
--0
--0
----
----
233.33%10K
----
Net other financing activities
-331.01%-2.1M
----
-31.22%-954K
24.14%-1.99M
67.15%-778K
-407.29%-487K
----
-348.77%-727K
-149.38%-2.63M
-241.70%-2.37M
Cash from discontinued financing activities
Financing cash flow
2,948.56%20.71M
74.57%-103K
-102.88%-699K
-35.92%22.92M
-101.39%-204K
-106.17%-727K
44.37%-405K
140.68%24.25M
3,506.10%35.76M
8,370.06%14.64M
Net cash flow
Beginning cash position
-80.23%3.79M
-90.82%4.69M
-64.99%11.87M
206.85%33.9M
-37.75%9.28M
147.98%19.17M
206.41%51.02M
206.85%33.9M
-36.43%11.05M
8.93%14.91M
Current changes in cash
127.20%2.67M
97.22%-881K
-140.61%-7.09M
-193.47%-21.87M
-88.39%2.21M
-237.51%-9.81M
-268.19%-31.73M
198.39%17.46M
464.57%23.4M
852.93%19.03M
Effect of exchange rate changes
122.22%18K
87.50%-15K
73.59%-89K
70.86%-160K
959.09%378K
-280.00%-81K
60.40%-120K
-36.44%-337K
-723.86%-549K
59.63%-44K
End cash Position
-30.22%6.48M
-80.23%3.79M
-90.82%4.69M
-64.99%11.87M
-64.99%11.87M
-37.75%9.28M
147.98%19.17M
206.41%51.02M
206.85%33.9M
206.85%33.9M
Free cash flow
-0.24%-4.95M
-5.11%-6.64M
-587.81%-5.87M
-36.09%-16.93M
-364.18%-4.82M
-6.17%-4.94M
-17.14%-6.32M
79.81%-853K
-32.27%-12.44M
177.67%1.83M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -15.53%-3.76M31.00%-3.62M-806.75%-4.61M11.95%-10.47M-230.75%-2.62M28.80%-3.25M0.06%-5.25M116.04%652K-33.30%-11.89M189.49%2M
Net income from continuing operations -368.21%-10.28M-788.32%-6.31M-163.44%-9.73M65.73%-6.72M76.63%-1.74M47.70%-2.2M121.04%916K-2.90%-3.69M-44.63%-19.6M-79.25%-7.46M
Operating gains losses 750.93%4.56M139.98%1.95M1,312.16%6.18M-169.76%-8.04M-117.71%-1.95M-1,198.15%-701K-1,634.59%-4.88M-292.45%-510K9,391.94%11.52M9,803.60%10.99M
Depreciation and amortization 6.49%361K13.33%357K21.45%368K2.44%1.3M21.83%346K0.30%339K-4.26%315K-5.61%303K2.75%1.27M2.90%284K
Other non cash items 198.49%458K80.77%-80K-218.85%-145K-691.74%-1.29M55.23%-531K-157.20%-465K-277.78%-416K-65.83%122K-87.07%218K-430.36%-1.19M
Change In working capital 118.18%98K83.98%-304K-147.13%-1.8M132.25%2.34M175.39%962K75.17%-539K6.64%-1.9M316.04%3.81M-4,571.60%-7.24M-261.72%-1.28M
-Change in receivables 28.92%-177K253.31%417K-103.66%-238K166.00%4.76M75.10%-1.22M59.05%-249K78.06%-272K1,533.70%6.51M-4,448.19%-7.22M-998.72%-4.92M
-Change in inventory 134.98%184K117.79%103K23.16%-448K-25.66%-906K792.04%782K-478.42%-526K-1,464.86%-579K17.89%-583K-380.54%-721K-263.77%-113K
-Change in payables and accrued expense -61.44%91K21.30%-824K47.52%-1.11M-318.99%-1.52M-62.59%1.4M113.87%236K-38.49%-1.05M-252.50%-2.12M366.28%695K2,069.36%3.75M
Cash from discontinued investing activities
Operating cash flow -15.53%-3.76M31.00%-3.62M-806.75%-4.61M11.95%-10.47M-230.75%-2.62M28.80%-3.25M0.06%-5.25M116.04%652K-33.30%-11.89M189.49%2M
Investing cash flow
Cash flow from continuing investing activities -145.13%-14.29M110.91%2.85M76.03%-1.78M-7,035.34%-34.32M109.85%5.03M-7,185.00%-5.83M-888.93%-26.08M-4,551.88%-7.44M-113.56%-481K2,165.52%2.4M
Net PPE purchase and sale 29.26%-1.19M-183.19%-3.02M16.35%-1.26M-1,064.68%-6.46M-1,169.54%-2.21M-1,930.12%-1.69M-671.74%-1.07M-840.63%-1.51M-13.50%-555K-50.00%-174K
Net investment purchase and sale -201.96%-13.56M120.86%5.34M81.89%-1.13M---29.8M160.70%6.52M---4.49M-924.01%-25.59M---6.24M--0--2.5M
Cash from discontinued investing activities
Investing cash flow -145.13%-14.29M110.91%2.85M76.03%-1.78M-7,035.34%-34.32M109.85%5.03M-7,185.00%-5.83M-888.93%-26.08M-4,551.88%-7.44M-113.56%-481K2,165.52%2.4M
Financing cash flow
Cash flow from continuing financing activities 2,948.56%20.71M74.57%-103K-102.88%-699K-35.92%22.92M-101.39%-204K-106.17%-727K44.37%-405K140.68%24.25M3,506.10%35.76M8,370.06%14.64M
Net issuance payments of debt 5.00%-228K-36.31%-214K-37.85%-244K---------32.60%-240K---157K0.56%-177K--------
Net common stock issuance --22.44M--0-98.02%499K-35.10%24.91M--0--055.40%-248K141.50%25.16M--38.38M--16.47M
Proceeds from stock option exercised by employees --600K--111K------0--0--0--------233.33%10K----
Net other financing activities -331.01%-2.1M-----31.22%-954K24.14%-1.99M67.15%-778K-407.29%-487K-----348.77%-727K-149.38%-2.63M-241.70%-2.37M
Cash from discontinued financing activities
Financing cash flow 2,948.56%20.71M74.57%-103K-102.88%-699K-35.92%22.92M-101.39%-204K-106.17%-727K44.37%-405K140.68%24.25M3,506.10%35.76M8,370.06%14.64M
Net cash flow
Beginning cash position -80.23%3.79M-90.82%4.69M-64.99%11.87M206.85%33.9M-37.75%9.28M147.98%19.17M206.41%51.02M206.85%33.9M-36.43%11.05M8.93%14.91M
Current changes in cash 127.20%2.67M97.22%-881K-140.61%-7.09M-193.47%-21.87M-88.39%2.21M-237.51%-9.81M-268.19%-31.73M198.39%17.46M464.57%23.4M852.93%19.03M
Effect of exchange rate changes 122.22%18K87.50%-15K73.59%-89K70.86%-160K959.09%378K-280.00%-81K60.40%-120K-36.44%-337K-723.86%-549K59.63%-44K
End cash Position -30.22%6.48M-80.23%3.79M-90.82%4.69M-64.99%11.87M-64.99%11.87M-37.75%9.28M147.98%19.17M206.41%51.02M206.85%33.9M206.85%33.9M
Free cash flow -0.24%-4.95M-5.11%-6.64M-587.81%-5.87M-36.09%-16.93M-364.18%-4.82M-6.17%-4.94M-17.14%-6.32M79.81%-853K-32.27%-12.44M177.67%1.83M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Adobe
ADBE
+0.50%
Lennar Corp
LEN
+0.46%
Petroleo Brasileiro SA Petrobras
PBR
+0.46%
Apple
AAPL
+0.32%
D.R. Horton
DHI
+0.30%

Unlock the Full List